| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0039 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |